Hepatitis B virus (HBV) core antigen-specific regulatory T cells confer sustained remission to anti-HBV therapy in chronic hepatitis B with acute exacerbation.

Koay, Lok-Beng

Hepatitis B virus (HBV) core antigen-specific regulatory T cells confer sustained remission to anti-HBV therapy in chronic hepatitis B with acute exacerbation. [electronic resource] - Human immunology Sep 2011 - 687-98 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1879-1166

10.1016/j.humimm.2010.11.001 doi


Antiviral Agents--therapeutic use
Cell Proliferation
Cytotoxicity, Immunologic
Epitope Mapping
Epitopes--metabolism
Forkhead Transcription Factors--biosynthesis
Hepatitis B Core Antigens--immunology
Hepatitis B virus--immunology
Hepatitis B, Chronic--drug therapy
Histocompatibility Antigens Class II--metabolism
Humans
Immunosuppression Therapy
Liver Failure
Protein Binding
Remission Induction
T-Cell Antigen Receptor Specificity
T-Lymphocyte Subsets--immunology
T-Lymphocytes, Regulatory--immunology